Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Douglas Miehm's Stock Ratings
RBC Capital Analyst
Douglas Miehm is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/18/2025
Overall Average Return
-10.8%
Smart Score
Overall Average Return Percentile
19th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/12/2025 | DHT/UN | Buy Now | DRI Healthcare Trust | — | — | Douglas Miehm40% | $18 → $19 | Maintains | Outperform | Get Alert |
| 05/02/2025 | BHC | Buy Now | Bausch Health Companies | $5.95 | 68.07% | Douglas Miehm40% | $8.5 → $10 | Maintains | Sector Perform | Get Alert |
| 05/02/2025 | BHC | Buy Now | Bausch Health Companies | $5.95 | 68.07% | Douglas Miehm40% | $8.5 → $10 | Maintains | Sector Perform | Get Alert |
| 04/17/2025 | WELL | Buy Now | WELL Health Technologies | $152.15 | -95.4% | Douglas Miehm40% | $7.5 → $7 | Maintains | Outperform | Get Alert |
| 04/04/2025 | BLCO | Buy Now | Bausch & Lomb | $11.58 | 46.8% | Douglas Miehm40% | $18 → $17 | Maintains | Outperform | Get Alert |
| 03/12/2025 | GUD | Buy Now | Knight Therapeutics | — | — | Douglas Miehm40% | $7 → $8 | Maintains | Outperform | Get Alert |
| 03/10/2025 | ONC | Buy Now | Oncolytics Biotech | $254.09 | -98.03% | Douglas Miehm40% | $6 → $5 | Maintains | Outperform | Get Alert |
| 03/10/2025 | ONCY | Buy Now | Oncolytics Biotech | $0.69 | 624.74% | Douglas Miehm40% | $6 → $5 | Maintains | Outperform | Get Alert |
| 02/20/2025 | BLCO | Buy Now | Bausch & Lomb | $11.58 | 55.44% | Douglas Miehm40% | $22 → $18 | Maintains | Outperform | Get Alert |
| 02/20/2025 | BLCO | Buy Now | Bausch & Lomb | $11.58 | 55.44% | Douglas Miehm40% | $22 → $18 | Maintains | Outperform | Get Alert |
| 01/30/2025 | BHC | Buy Now | Bausch Health Companies | $5.95 | 68.07% | Douglas Miehm40% | $11 → $10 | Maintains | Neutral | Get Alert |
| 01/30/2025 | BHC | Buy Now | Bausch Health Companies | $5.95 | 68.07% | Douglas Miehm40% | $11 → $10 | Maintains | Sector Perform | Get Alert |
| 01/29/2025 | BLCO | Buy Now | Bausch & Lomb | $11.58 | 89.98% | Douglas Miehm40% | $23 → $22 | Maintains | Outperform | Get Alert |
| 01/29/2025 | BLCO | Buy Now | Bausch & Lomb | $11.58 | 89.98% | Douglas Miehm40% | $23 → $22 | Maintains | Outperform | Get Alert |
| 01/07/2025 | WELL | Buy Now | WELL Health Technologies | $152.15 | -94.41% | Douglas Miehm40% | $7 → $8.5 | Maintains | Outperform | Get Alert |
| 12/11/2024 | LGND | Buy Now | Ligand Pharmaceuticals | $112.54 | 27.07% | Douglas Miehm40% | $141 → $143 | Maintains | Outperform | Get Alert |
